Key result
Repeated surgical resection of recurrent primary pleural synovial sarcoma achieved long-term survival, with the patient remaining alive 12 years after the initial surgery.
Why the study?
Primary pleural synovial sarcoma is an aggressive malignant tumour whose treatment strategy has not been fully established due to its rarity.
Does repeated surgical resection improve survival in a patient with primary pleural synovial sarcoma?
Case Report (n=1)
Does repeated surgical resection improve survival in a patient with primary pleural synovial sarcoma?
Repeated surgical resection of recurrent lesions can achieve long-term survival in patients with primary pleural synovial sarcoma.
May support repeated resection in select recurrent cases; leaves open survival benefit for this rare tumor.
Primary pleural synovial sarcoma is a malignant tumour and thought to be more aggressive than synovial sarcoma which occurs in extremities. Its treatment strategy has not been fully established because of its rarity. We report a primary pleural synovial sarcoma case which achieved a long-term survival with repeated surgery of recurrent pleural tumour. A 39-year-old man presented with a gradually enlarged tumour in the left hemithorax. The tumour was resected and diagnosed as primary pleural synovial sarcoma. The tumour was slowly growing and repeatedly recurrent in the left pleura. The surgical resections for the recurrent tumours were performed 6 years and 11 years after the initial surgery. Intriguingly, recurrent tumour which developed after second surgery exhibited temporally spontaneous regression. Our patient remains alive 12 years after the initial surgery. Repeated resection of metastatic lesion can achieve long survival in primary pleural synovial sarcoma.
No takes yet. Share an insight, caveat, or question.
Katsurada et al. (2019) conducted a case report in Primary pleural synovial sarcoma (n=1). Repeated surgical resection was evaluated on Long-term survival. Repeated surgical resection of recurrent primary pleural synovial sarcoma achieved long-term survival, with the patient remaining alive 12 years after the initial surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: